Abstract
A special committee of the “Erician Drug Registration Agency” must consider the following problems which relate to the “Post-Marketing” surveillance issue.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Jick, H., Walker, A.M. and Spriet-Pourra, C. Post-marketing Follow-up. J Am Med Assoc. 1979; 242: 2310–2314.
Slone, D., Shapiro, S., Miettinen, O.S. Case control surveillance of serious illnesses attributable to ambulatory drug use, in Epidemiological Evaluation of Drugs, edited by Colombo, F., Shapiro, S., Slone D., Tagnoni, G. Littleton, Massachusetts Publishing Sciences Group, Inc. 1977; pp 59–70.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer Science+Business Media New York
About this chapter
Cite this chapter
Jones, J.K. (1981). Post-Marketing Surveillance: Hypothetical Problems. In: Wardell, W.M., Velo, G. (eds) Drug Development, Regulatory Assessment, and Postmarketing Surveillance. NATO Advanced Study Institutes Series, vol 39. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4055-3_36
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4055-3_36
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4057-7
Online ISBN: 978-1-4684-4055-3
eBook Packages: Springer Book Archive